A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor.

Louise EvansRick WalkerJennifer MacDiarmidHimanshu BrahmbhattAntoinette AnazodoGeoffrey McCowageAndrew J GiffordMaria KavallarisToby TrahairDavid S Ziegler

Published in: Targeted oncology (2024)

NCT02687386.

Keyphrases

epidermal growth factor receptor
tyrosine kinase
advanced non small cell lung cancer
young adults
open label
high dose
blood brain barrier
clinical trial
randomized controlled trial
study protocol
wild type